MGC Pharmaceuticals (ASX:MXC) Share Price and News - StockTrack

Market Cap (29-Apr) $18,417,672 (949th)	Close (30-Jun) $0.005 0 (0%)	Volume (30-Jun) 14,697,042	Shortsold (2-Apr) 218 (0.00%) (630th)
52w High $9.00	52w Low $0.300	P/E 14.90	EPS -3.21

	Subject
	MXC MXC Ann: MGC PHARMA TO ACQUIRE MEDICAL RESEARCH COMPANY MEDICANL
	1 (current) 2 3
	MXC MXC Ann: Appendix 2A - Option Conversion
	MXC MXC Ann: INVESTOR PRESENTATION
	MXC MXC Ann: Proposed issue of Securities - MXC
	MXC MXC Ann: Change of Company Secretary, Perf Rights & Remuneration
	MXC MXC Ann: MXC COMPLETES FIRST ARTEMIC ORDER, MARCH QTR RECORD REVENUE
	MXC MXC Ann: Results of General Meeting
	MXC MXC Ann: Appendix 2A
	MXC MXC Ann: Ethics Committee Approval Granted Phase III Clinical Trial
	MXC MXC Ann: MGC Pharma General Meeting Information and Webinar
	MXC MXC Ann: Appendix 2A
	MXC MXC Ann: Change of Director's Interest x3
	MXC MXC Ann: SwissPharmaCan AG increases initial purchase order
	MXC MXC Ann: Half Yearly Report and Accounts
	MXC MXC Ann: Notice of Meeting and Incentive Share Plan
	MXC MXC Ann: Master Suppy and Distribution Agreement for ArtemiC Rescue
	MXC MXC Ann: LSE Dual Listing & Depositary Interest Information
	MXC MXC Ann: New In-vitro cannabinoid study on Glioblastoma treatment
	MXC MXC Ann: Corporate Governance Plan
	MXC MXC Ann: Appendix 2A
	MXC MXC Ann: MGC Pharma Welcomes Admission to the LSE
	MXC MXC Ann: Proposed issue of Securities - MXC
	MXC MXC Ann: Disclosure Document
	MXC MXC Ann: Proposed issue of Securities - MXC
	MXC MXC Ann: MGC Pharma first medicinal cannabis company to list on LSE
	MXC MXC Ann: Trading Halt
	MXC MXC Ann: MGC Pharma Investor Presentation
	MXC MXC Ann: MGC Pharma to list on the London Stock Exchange
	MXC MXC Ann: December Quarterly Activity and Cashflow Report
	MXC MXC Ann: Key Appointment - Global Chief Sales Officer
	MXC MXC Ann: Appendix 2A
	MXC MXC Ann: MGC Pharma to receive grant for Malta production facility
	MXC MXC Ann: ArtemiC Phase II Clinical Trial Results
	MXC MXC Ann: Appendix 2A
	MXC MXC Ann: Completion of Unmarketable Parcel Share Sale Facility
	MXC MXC Ann: ArtemiC Phase II Clinical Trial Results Update
	MXC MXC Ann: MGC Pharma to benefit from UN vote to reschedule Cannabis
	MXC MXC Ann: Amended MGC Nutraceuticals Sales Update
	MXC MXC Ann: MGC Nutraceuticals Sale Update
	MXC MXC Ann: Company Secretary Appointment
	MXC MXC Ann: Issue of Securities - Appendix 2A
	MXC MXC Ann: Prospectus
	MXC MXC Ann: Proposed issue of Securities - MXC
	MXC MXC Ann: Drawdown of $3.5m Convertible Note
	MXC MXC Ann: MGC PHARMA COMPLETES ACQUISITION OF TELEHEALTH PLATFORM MCC
	MXC MXC Ann: FURTHER SUCCESSFUL RESULTS FROM GLIOBLASTOMA RESEARCH
	MXC MXC Ann: Conversion of Convertible Notes - Appendix 2A
	MXC MXC Ann: COMPLETION OF PHASE II CLINICAL TRIAL ON COVID-19 PATIENTS
	MXC MXC Ann: Constitution
	MXC MXC Ann: Results of Annual General Meeting

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.42	6,035	0.00 (0.00%)
26-Apr	$0.42	1,033	+0.01 (2.47%)
24-Apr	$0.41	6,603	-0.03 (5.81%)
23-Apr	$0.43	0	0.00 (0.00%)
22-Apr	$0.43	5,109	0.00 (0.00%)
19-Apr	$0.43	4,257	0.00 (0.00%)
18-Apr	$0.43	0	0.00 (0.00%)
17-Apr	$0.43	2	-0.01 (1.15%)
16-Apr	$0.44	18,828	-0.01 (2.25%)
15-Apr	$0.45	11,403	0.00 (0.00%)
12-Apr	$0.45	49,208	+0.01 (2.30%)
11-Apr	$0.44	8,542	+0.02 (4.82%)
10-Apr	$0.42	6,145	-0.02 (3.49%)
09-Apr	$0.43	43,411	+0.02 (3.61%)
08-Apr	$0.42	27,077	+0.01 (1.22%)
5 up, 4 down, and 6 flat days

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

MGC Pharmaceuticals Health Care

$0.005 (0%)

$0.005 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices